[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Latin America Protein Purification & Isolation Market Size, Share & Trends Analysis Report By Product, By Technology (Chromatography, Electrophoresis), By Application, By End Use, By Country, And Segment Forecasts, 2025 - 2030

October 2024 | 100 pages | ID: L32589EF968EEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Latin America Protein Purification & Isolation Market Growth & Trends

The Latin America protein purification & isolation market size is estimated treach USD 1.26 billion by 2030, expanding at a CAGR of 9.0% from 2025 t2030, according ta new report by Grand View Research, Inc. Rising R&D activities by pharmaceutical companies are expected tboost the demand for purification & isolation of proteins for preclinical drug development phase.

In addition, technology is advancing in line with the rising need for more accurate and rapid purification & isolation of proteins. For instance, ProteoSpin Inclusion Body Protein Isolation Micrand Maxi Kits rapidly isolates body proteins under 60 minutes. Thus, increasing use of rapid and robust kits is expected tfuel the market growth during the forecast period.

Furthermore, favorable government policies are anticipated tboost the market growth. The NAFTA renegotiation in Mexicis focusing on shaping regulatory frameworks and laws tfacilitate international transfer of skills and capital. The NAFTA renegotiation and Trans-Pacific Partnership negotiations are expected tlead tthe growth of the biotechnology market in this country.

Increase in academic institutes conducting research studies on protein purification is anticipated tboost the development of new ways tcombat diseases, thereby fueling market growth. For instance, in November 2017, a study research was published in Protein Expression and Purification demonstrating purification of Andes virus glycoproteins Gn and Gcto. It was found that the protein can be useful in development of a vaccine against Andes virus.

Brazil dominated the market in 2019 owing tthe presence of well-established computational approaches for analyzing various techniques, advancements in mass spectrometry-based purification methods combined with new researches in this field that strengthen research and emphasize the importance of science in the Brazilian society. However, Chile is anticipated tbe the fastest-growing country during the forecast period.

Latin America Protein Purification & Isolation Market Report Highlights
    • Consumables dominated the market in 2024 owing tthe easy availability of advanced purification kits that enable rapid & accurate screening, purification, preparation, and concentration of protein samples
  • In March 2024, Bio-Rad Laboratories, Inc. appointed Roop K. Lakkaraju as Executive Vice President and Chief Financial Officer, effective April 15, leveraging his extensive financial leadership experience from Benchmark Electronics and other firms.
    • Protein-protein interaction studies was the dominant application segment in 2024 due tits high adoption for deriving highly purified proteins
      • The drug screening segment is projected twitness the highest growth rate over the forecast period owing tthe development of drugs with a higher efficacy & fewer side effects than existing drugs
    • Academic and research institutes held the largest share of the market in 2024 due tthe increased number of research initiatives in academic institutes for structural & functional proteomics
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Segment Definitions
  1.2.1. Product
  1.2.2. Technology
  1.2.3. Application
  1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
  1.5.1. Purchased Database
  1.5.2. GVR’s Internal Database
  1.5.3. Secondary Sources
  1.5.4. Primary Research
1.6. Information Analysis
  1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
  1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
  3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
  3.3.1. Industry Analysis - Porter’s Five Forces Analysis
    3.3.1.1. Supplier Power
    3.3.1.2. Buyer Power
    3.3.1.3. Substitution Threat
    3.3.1.4. Threat of New Entrants
    3.3.1.5. Competitive Rivalry
  3.3.2. PESTLE Analysis

CHAPTER 4. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET: PRODUCT BUSINESS ANALYSIS

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Consumables
  4.4.1. Consumables Market, 2018 - 2030 (USD Million)
4.5. Instruments
  4.5.1. Instruments Market, 2018 - 2030 (USD Million)

CHAPTER 5. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET: TECHNOLOGY BUSINESS ANALYSIS

5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Chromatography
  5.4.1. Chromatography Market, 2018 - 2030 (USD Million)
5.5. Electrophoresis
  5.5.1. Electrophoresis Market, 2018 - 2030 (USD Million)
5.6. Ultrafiltration
  5.6.1. Ultrafiltration Market, 2018 - 2030 (USD Million)
5.7. Precipitation
  5.7.1. Precipitation Market, 2018 - 2030 (USD Million)
5.8. Western Blotting
  5.8.1. Western Blotting Market, 2018 - 2030 (USD Million)
5.9. Others
  5.9.1. Others Market, 2018 - 2030 (USD Million)

CHAPTER 6. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET: APPLICATION BUSINESS ANALYSIS

6.1. Application Market Share, 2024 & 2030
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Protein-Protein Interaction Studies
  6.4.1. Protein-Protein Interaction Studies Market, 2018 - 2030 (USD Million)
6.5. Biomarker Discovery
  6.5.1. Biomarker Discovery Market, 2018 - 2030 (USD Million)
6.6. Drug Screening
  6.6.1. Drug Screening Market, 2018 - 2030 (USD Million)
6.7. Diagnostics
  6.7.1. Diagnostics Market, 2018 - 2030 (USD Million)

CHAPTER 7. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET: END USE BUSINESS ANALYSIS

7.1. End Use Market Share, 2024 & 2030
7.2. End Use Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Academic and Research Institutes
  7.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
7.5. Pharmaceutical and Biotechnological Companies
  7.5.1. Pharmaceutical and Biotechnological Companies Market, 2018 - 2030 (USD Million)
7.6. Hospitals
  7.6.1. Hospitals Market, 2018 - 2030 (USD Million)
7.7. CROs
  7.7.1. CROs Market, 2018 - 2030 (USD Million)

CHAPTER 8. LATIN AMERICA PROTEIN PURIFICATION & ISOLATION MARKET: COUNTRY ESTIMATES & TREND ANALYSIS BY PRODUCT, TECHNOLOGY, APPLICATION, AND END USE

8.1. Country Market Share Analysis, 2024 & 2030
8.2. Country Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. Brazil
  8.4.1. Key Country Dynamics
  8.4.2. Regulatory Framework
  8.4.3. Competitive Insights
  8.4.4. Brazil Protein Purification & Isolation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Argentina
  8.5.1. Key Country Dynamics
  8.5.2. Regulatory Framework
  8.5.3. Competitive Insights
  8.5.4. Argentina Protein Purification & Isolation Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Rest of Latin America
  8.6.1. Key Country Dynamics
  8.6.2. Regulatory Framework
  8.6.3. Competitive Insights
  8.6.4. Rest of Latin America Protein Purification & Isolation Market Estimates And Forecasts, 2018 - 2030 (USD Million)

CHAPTER 9. COMPETITIVE LANDSCAPE

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
  9.5.1. Thermo Fisher Scientific, Inc.
    9.5.1.1. Overview
    9.5.1.2. Financial Performance
    9.5.1.3. Product Benchmarking
    9.5.1.4. Strategic Initiatives
  9.5.2. Merck KGaA
    9.5.2.1. Overview
    9.5.2.2. Financial Performance
    9.5.2.3. Product Benchmarking
    9.5.2.4. Strategic Initiatives
  9.5.3. Bio-Rad Laboratories, Inc.
    9.5.3.1. Overview
    9.5.3.2. Financial Performance
    9.5.3.3. Product Benchmarking
    9.5.3.4. Strategic Initiatives
  9.5.4. Agilent Technologies, Inc.
    9.5.4.1. Overview
    9.5.4.2. Financial Performance
    9.5.4.3. Product Benchmarking
    9.5.4.4. Strategic Initiatives
  9.5.5. Promega Corporation
    9.5.5.1. Overview
    9.5.5.2. Financial Performance
    9.5.5.3. Product Benchmarking
    9.5.5.4. Strategic Initiatives
  9.5.6. General Electric Company
    9.5.6.1. Overview
    9.5.6.2. Financial Performance
    9.5.6.3. Product Benchmarking
    9.5.6.4. Strategic Initiatives
  9.5.7. Norgen Biotek Corp.
    9.5.7.1. Overview
    9.5.7.2. Financial Performance
    9.5.7.3. Product Benchmarking
    9.5.7.4. Strategic Initiatives


More Publications